Yescarta® (axicabtagene ciloleucel)
for Lymphoma

Yescarta (axicabtagene ciloleucel) is a CAR T-cell therapy used to treat large B-cell lymphoma and follicular lymphoma. It’s made from your own T-cells, which are modified to target CD19 on cancer cells. Once infused, these enhanced cells recognize and destroy lymphoma cells. Yescarta is given as a 30-minute IV infusion and helps boost the immune system’s ability to fight cancer.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Lymphoma